Literature DB >> 28521377

[Checklist for the Development and Assessment of Cost-of-Illness Studies].

Dirk Müller1, Stephanie Stock1, Charalabos-Markos Dintsios2, Nadja Chernyak3, Andreas Gerber-Grote4, Tristan Daniel Gloede5, Benita Hermann5, Eduard Huppertz6, Fabian Jülich7, Sarah Mostardt8, Juliane Köberlein-Neu9, Anne Prenzler10, Hans-Joachim Salize11, Sara Santos12, Benjamin Scheckel1, Astrid Seidl13, Katharina Wahlers1, Andrea Icks3.   

Abstract

BACKGROUND: Cost-of-illness (CoI) studies are important instruments for estimating the socioeconomic burden of specified diseases. CoI studies provide important information about the cost structure of a disease, the resulting research need, approaches to improve aspects of care and, monetary consequences from different perspectives. This information can be useful for healthcare research and health policy. Due to heterogeneity of available Cost-of-Illness studies, the working group 'Health Economics' of the German Network for Healthcare Research (DNVF) in accordance with the German Society for Health Economics (DGGÖ) developed an instrument for the planning, conduct and assessment of CoI studies.
METHODS: The checklist was developed based on a systematic literature search of published national and international checklists as well as guidelines and recommendations for development and assessment of CoI studies and health economic evaluations. Structure and subject matter of the generic checklist was designed, approved and, finally, examined in a pretest by the working group.
RESULTS: Based on the results of the literature search (n=2 454), 58 articles were used for the identification of relevant criteria for the checklist. With respect to the results of the pretest, 6 dimensions were included in the checklist: (i) general aspects, (ii) identification of resources, (iii) description and quantification of resource consumption, (iv) valuation of resources (v) analysis and presentation of results and (vi) discussion and conclusion. In total, the 6 dimensions were operationalized through 37 items.
CONCLUSION: This checklist is an initial approach to improve transparency and understanding of CoI studies in terms of the extent, structure and development of the socioeconomic burden of diseases. The checklist supports the comparability of different studies and facilitates study conception. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28521377     DOI: 10.1055/s-0042-124664

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  2 in total

1.  Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol.

Authors:  Heidrun Golla; Charlotte Nettekoven; Claudia Bausewein; Jörg-Christian Tonn; Niklas Thon; Berend Feddersen; Oliver Schnell; Christopher Böhlke; Gerhild Becker; Roman Rolke; Hans Clusmann; Ulrich Herrlinger; Lukas Radbruch; Hartmut Vatter; Erdem Güresir; Stephanie Stock; Dirk Müller; Daniele Civello; Irini Papachristou; Martin Hellmich; Stefanie Hamacher; Raymond Voltz; Roland Goldbrunner
Journal:  BMJ Open       Date:  2020-01-07       Impact factor: 2.692

2.  The economic burden of obesity in Italy: a cost-of-illness study.

Authors:  Margherita d'Errico; Milena Pavlova; Federico Spandonaro
Journal:  Eur J Health Econ       Date:  2021-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.